ABCL575 — Topline data
Q4 2026
● Completed dosing for the Phase 1 study of ABCL575, with top-line data readout expected in Q4 2026.Source filing
ABCL biotech catalysts & pipeline
ABCELLERA BIOLOGICS INC · Data as of 2026-10-25
Upcoming catalysts
ABCL688 — IND submission
2027
We anticipate submission of an IND/CTA for ABCL688 in 2027.Source filing